We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
CALL
Barrick Mining
B
$60.9B
| $1.47M | ﹤0.01% |
+40,000
| New | +$1.64M |
2026 Q2
0 quarters
|
|
1927
Blackbaud
BLKB
$2.41B
| $1.47M | ﹤0.01% |
49,584
-7,136
| -13% | -$235K |
2025 Q3
3 quarters
|
|
1928
CALL
Automatic Data Processing
ADP
$116B
| $1.46M | ﹤0.01% |
6,500
-1,100
| -14% | -$235K |
2025 Q3
3 quarters
|
|
1929
Columbia Sportswear
COLM
$3.46B
| $1.45M | ﹤0.01% |
+23,476
| New | +$1.45M |
2026 Q2
0 quarters
|
|
1930
Gold.com Inc
GOLD
$1.11B
| $1.45M | ﹤0.01% |
34,868
-18,981
| -35% | -$816K |
2025 Q3
3 quarters
|
|
1931
ArcBest
ARCB
$2.8B
| $1.44M | ﹤0.01% |
+10,030
| New | +$1.31M |
2026 Q2
0 quarters
|
|
1932
Goosehead Insurance
GSHD
$1.13B
| $1.44M | ﹤0.01% |
+29,598
| New | +$1.22M |
2026 Q2
0 quarters
|
|
1933
Beam Therapeutics
BEAM
$2.81B
| $1.43M | ﹤0.01% |
+41,792
| New | +$1.26M |
2026 Q2
0 quarters
|
|
1934
Williams-Sonoma
WSM
$29.8B
| $1.43M | ﹤0.01% |
6,144
+4,362
| +245% | +$865K |
2024 Q4
6 quarters
|
|
1935
PUT
TeraWulf
WULF
$5.85B
| $1.43M | ﹤0.01% |
57,800
+27,800
| +93% | +$639K |
2025 Q2
4 quarters
|
|
1936
Woodward
WWD
$18B
| $1.43M | ﹤0.01% |
3,353
+2,704
| +417% | +$1.03M |
2025 Q2
4 quarters
|
|
1937
Construction Partners
ROAD
$5.1B
| $1.42M | ﹤0.01% |
11,995
+1,375
| +13% | +$163K |
2024 Q1
9 quarters
|
|
1938
Atrium Therapeutics
RNA
$141M
| $1.42M | ﹤0.01% |
105,875
-129,240
| -55% | -$1.69M |
2026 Q1
1 quarter
|
|
1939
Vulcan Materials
VMC
$36.1B
| $1.42M | ﹤0.01% |
4,821
+2,746
| +132% | +$787K |
2025 Q4
2 quarters
|
|
1940
PUT
Procore
PCOR
$9.33B
| $1.42M | ﹤0.01% |
+35,000
| New | +$1.73M |
2026 Q2
0 quarters
|
|
1941
PUT
Peloton Interactive
PTON
$2.25B
| $1.42M | ﹤0.01% |
240,000
| – | – |
2025 Q3
3 quarters
|
|
1942
Dream Finders Homes
DFH
$886M
| $1.42M | ﹤0.01% |
82,105
-27,361
| -25% | -$402K |
2024 Q4
6 quarters
|
|
1943
CALL
Dave Inc
DAVE
$4.04B
| $1.42M | ﹤0.01% |
+3,800
| New | +$988K |
2026 Q2
0 quarters
|
|
1944
CALL
Abivax
ABVX
$7.58B
| $1.41M | ﹤0.01% |
+10,600
| New | +$1.2M |
2026 Q2
0 quarters
|
|
1945
CALL
Salesforce
CRM
$189B
| $1.41M | ﹤0.01% |
9,000
-38,600
| -81% | -$6.79M |
2022 Q3
15 quarters
|
|
1946
CALL
Antero Resources
AR
$12.9B
| $1.41M | ﹤0.01% |
40,100
| – | – |
2025 Q4
2 quarters
|
|
1947
Truist Financial
TFC
$58.5B
| $1.41M | ﹤0.01% |
28,263
-2,108
| -7% | -$104K |
2024 Q3
7 quarters
|
|
1948
CALL
CSX Corp
CSX
$96.3B
| $1.4M | ﹤0.01% |
+29,500
| New | +$1.33M |
2026 Q2
0 quarters
|
|
1949
Stellantis
STLA
$13.5B
| $1.4M | ﹤0.01% |
244,272
-5,583,866
| -96% | -$41.3M |
2025 Q4
2 quarters
|
|
1950
PUT
EchoStar
ECHO
$28.2B
| $1.4M | ﹤0.01% |
+13,800
| New | +$1.69M |
2026 Q2
0 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.